The groundbreaking therapy of the medication represents a exciting advance in the care of the condition. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide741597.frewwebs.com/40700268/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment